News
Public · Published
agilon health, inc. reports results for the quarter ended September 30 - Earnings Summary
Agilon health reported adjusted earnings of $1.97 per share for the quarter ended September 30, compared with a loss per share a year earlier, and analysts had expected a loss of $1.19 per share. Revenue rose 5.9% to $1.52 billion, above the $1.46 billion forecast, and net income was $34.91 million.
Published:
Updated:
What happened
Agilon health reported adjusted earnings of $1.97 per share for the quarter ended September 30, compared with a loss per share a year earlier, and analysts had expected a loss of $1.19 per share. Revenue rose 5.9% to $1.52 billion, above the $1.46 billion forecast, and net income was $34.91 million.
Confirmed
Global impact / market context
The earnings and revenue beat indicate stronger reported results than analysts expected, which can improve confidence in the company’s ability to generate income from its healthcare services. If stronger performance continues, it could support cash available for operations, though one quarter alone does not establish a lasting trend.
Analyst inference
Analysts’ average rating is hold, despite a buy consensus for the broader healthcare facilities and services peer group. The company’s shares had already risen 10.3% this quarter and 409.9% year to date, so investors will weigh the results against substantial prior gains.
Confirmed
What to watch
- Future quarterly revenue and earnings can show whether the latest growth and positive net income persist, rather than reflecting a one-quarter improvement. Analyst inference
- Analyst estimates rose about 4.9% over three months, but one analyst cut an earnings estimate in the last 30 days; further revisions may signal changing expectations. Confirmed
- The $115 median 12-month analyst price target was about 16.3% above the last close of $96.23; subsequent results may affect that forecast. Confirmed
Evidence
- Original source link unavailable